Edition:
United States

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

7.74USD
30 Sep 2016
Change (% chg)

$-0.05 (-0.64%)
Prev Close
$7.79
Open
$7.93
Day's High
$7.93
Day's Low
$7.74
Volume
951
Avg. Vol
1,019
52-wk High
$8.22
52-wk Low
$5.60

ICCC.OQ

Chart for ICCC.OQ

About

ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle,... (more)
No analyst recommendations are available for ICCC.OQ.

Overall

Beta: 0.50
Market Cap(Mil.): $32.31
Shares Outstanding(Mil.): 4.18
Dividend: --
Yield (%): --

Financials

  ICCC.OQ Industry Sector
P/E (TTM): 24.37 43.83 36.83
EPS (TTM): 0.32 -- --
ROI: 7.19 -0.29 13.93
ROE: 8.27 -2.99 14.84

BRIEF-Immucell posts Q2 earnings per share $0.00

* Q2 earnings per share $0.00 Source text for Eikon: Further company coverage:

Aug 11 2016

BRIEF-Immucell Q1 earnings per share $0.11

* Q1 sales fell 3.7 percent to $3.0 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 11 2016

BRIEF-Immucell appoints Elizabeth Williams vice president of manufacturing operations

* Immucell appoints Elizabeth Williams vice president of manufacturing operations Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Apr 04 2016

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $62.41 +0.50
Pfizer Inc. (PFE.N) $33.87 +0.55
Eli Lilly and Co (LLY.N) $80.26 +0.52

Earnings vs. Estimates

No consensus analysis data available.